Table 1.
Characteristics of the subjects.
| N | Results | |
|---|---|---|
| Age (years) | 30 | 8.33 (3.44–12.67) |
| Male (%) | 30 | 16 (53%) |
| Female (%) | 30 | 14 (47%) |
| Duration (days) | 30 | 14 (2–1095) |
| Signs and symptoms | ||
| Headache (%) | 28 | 25 (89%) |
| Vomiting (%) | 30 | 22 (73%) |
| Visual symptoms (%) | 29 | 12 (41%) |
| Weak (%) | 29 | 5 (17%) |
| Seizures (%) | 30 | 9 (30%) |
| Coma (%) | 30 | 7 (23%) |
| Fever (%) | 30 | 4 (13%) |
| Dyskinesia (%) | 29 | 4 (14%) |
| Etiologies | ||
| Infection (%) | 30 | 7 (23%) |
| Tumor (%) | 30 | 3 (10%) |
| Nephritis or nephrotic syndrome (%) | 30 | 8 (27%) |
| Traumatic brain injury (%) | 30 | 1 (3%) |
| Unknown (%) | 30 | 11 (37%) |
| Lesion site on MRV | ||
| Superior sagittal sinus (%) | 20 | 15 (75%) |
| Inferior sagittal sinus (%) | 20 | 2 (10%) |
| Straight sinus (%) | 20 | 6 (30%) |
| Left transverse sinus (%) | 20 | 12 (60%) |
| Right transverse sinus (%) | 20 | 14 (70%) |
| Left sigmoid sinus (%) | 20 | 7 (35%) |
| Right sigmoid sinus (%) | 20 | 9 (45%) |
| Cavernous sinus (%) | 20 | 1 (5%) |
| Parenchymal involvement (%) | 20 | 1 (5%) |
| Laboratory tests | ||
| D-dimer (mg/L) | 20 | 1.65 (0.61–2.97) |
| Prothrombin time (seconds) | 20 | 12.8 (11.4–13.7) |
| Active partial thrombin time (seconds) | 20 | 31.2 (26.9–36.0) |
| Thrombin time (seconds) | 20 | 17.6 (15.9–19.7) |
| Fibrinogen (g/L) | 20 | 3.41 (2.81–4.61) |
| Hemoglobin (g/L) | 19 | 128 (115–140) |
| White blood cell (109/L) | 19 | 7.9 (5.4–12.9) |
| Platelet (109/L) | 19 | 263 (192–386) |
| C-reactive protein (mg/L) | 19 | 8 (8–8) |
| Outcome | ||
| Died (%) | 30 | 2 (7%) |
| Alive (%) | 30 | 26 (87%) |
| Transferred (%) | 30 | 2 (7%) |
Continuous data were expressed as median and interquartile range and categorical data were expressed as absolute number (percentage).